In a recent interview, Josh Alvernia, CEO of Wrango, shared how his company is reshaping pharmaceutical marketing through data-driven insights and identity resolution. Starting with a digital agency focused on customer acquisition, Alvernia identified a growing need in healthcare marketing—specifically, targeting healthcare practitioners (HCPs) effectively across both the U.S. and Canada. Wrango emerged as the solution, bridging gaps in measurement, personalization and compliance. According to Alvernia, the industry’s biggest shift is its new accountability to the bottom line, as marketing teams are increasingly expected to do what sales once did: close the deal.
Alvernia also discussed how real-world data and AI are helping marketers understand not just who HCPs are professionally, but what drives them personally. From device preferences to entertainment habits, Wrango provides pharmaceutical brands with a comprehensive view of their target audience—before any campaign even begins. As regulation tightens and expectations for outcomes increase, Alvernia sees AI playing a key role in forecasting optimal moments for engagement. To hear more about how Wrango is navigating the evolving pharma landscape and leading innovations on both sides of the border, watch the full interview.
The editorial staff had no role in this post's creation.